Anna Krylova, MD | |
55 Lake Ave N, Worcester, MA 01655-0002 | |
(508) 334-1000 | |
Not Available |
Full Name | Anna Krylova |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 55 Lake Ave N, Worcester, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487093712 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 256796 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Anna Krylova, MD 55 Lake Ave N, Worcester, MA 01655-0002 Ph: (508) 334-1000 | Anna Krylova, MD 55 Lake Ave N, Worcester, MA 01655-0002 Ph: (508) 334-1000 |
News Archive
Although scientists are reluctant to officially endorse green tea as a cancer prevention method, evidence continues to grow about its protective effects, including results of a new study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, which suggests some reduction in oral cancer.
The immune system is a complex and powerful weapon that provides protection against bacteria and viruses that, if left unchecked, would wreak havoc throughout the human body.
Crux Biomedical® was named one of "50 Companies to Watch" in an annual survey of medical device and diagnostic companies. The survey, conducted by Medical Device and Diagnostics Industry (MD+DI), was published in its June 2010 issue. The purpose of the survey was to identify firms that have either achieved success or have the potential to revolutionize medical practice with their respective products.
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive results in its Phase 2 clinical trial, in which SGX942, a first-in-class Innate Defense Regulator (IDR), at a dose of 1.5 mg/kg, successfully reduced the median duration of severe oral mucositis by 50% in all patients and by 67% in patients receiving the most aggressive chemoradiation therapy (CRT) for treatment of their head and neck cancer.
› Verified 9 days ago
Marissa E Parrillo, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 774-442-5545 Fax: 774-443-7042 | |
Dr. Penny M. Feldman, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 774-441-8081 Fax: 774-441-8055 | |
Dr. Linda D Sagor, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Department Of Pediatrics, Worcester, MA 01655 Phone: 508-856-4198 Fax: 508-856-1042 | |
Dr. Robert W Zavoski, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 26 Queen Street, Worcester, MA 01610 Phone: 508-860-7800 Fax: 508-860-7925 | |
Cornelius T Tyrrell, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Department Of Pediatrics, Worcester, MA 01655 Phone: 508-334-7986 Fax: 508-334-7989 | |
Callie M Stone, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
Nura El-haj, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 774-441-8083 Fax: 774-441-8057 |